The present invention generally relates to medical devices for protecting a patient from distal embolization during interventional procedures, such as angioplasty or stent placement for treatment of vascular stenosis. More particularly, the devices comprise a catheter having irrigation and aspiration capabilities, and a guidewire carrying a distal expandable occluder. An endovascular instrument, such as an angioplasty catheter, is insertable into a lumen of the aspiration catheter.
Treatments of vascular stenosis or lesions during endovascular procedures, such as atherectomy, balloon angioplasty with or without stent placement, or ablation therapy, are associated with increased risk of distal embolization. Tissue debris, calcium, atheromatous plaque, and/or thrombi generated during the procedure often become lodged downstream in a small vessel of vital organs, causing tissue ischemia or infarction. For example, transient ischemic attack (TIA) and cerebral infarction (stroke) are common complications of performing endovascular procedures on the ascending aorta and the carotid artery.
To reduce the risk of distal embolism, several devices are employed for use in endovascular procedures. For example, blood filters can be deployed distal to a vascular lesion to capture emboli. However, disadvantages associated with the blood filters are that (1) dislodgment of embolic material can occur during insertion and retrieval of the filter device, and (2) blood filters cannot easily be used in small vessels, (e.g., a saphenous vein graft measuring 3 or 4 mm).
Another catheter system described in U.S. Pat. No. 5,833,650 includes occlusion members for providing proximal and distal occlusion to a vascular lesion. Each occlusion member communicates with an inflation lumen. The catheter includes irrigation and aspiration lumens for removing embolic debris generated during the procedure. The catheter also includes a device introducing lumen, which further increases the overall size and diameter of the catheter, making the catheter impracticable for use in smaller vessels.
Theron developed a device having an insertion catheter, a dilation catheter, and an occlusion catheter assembled in a coaxial arrangement, U.S. Pat. No. 5,423,742. The catheter device is inserted across a vascular lesion which is dilated by the dilation catheter. Emboli generated during the dilation is removed by suction through the insertion catheter, while the occlusion catheter provides vascular occlusion distal to the vascular lesion. The major disadvantage associated with the device is that some of the embolic material will not be removed by irrigation and suction, thereby leaving the patient at risk for embolic complication.
Thus, there is a need for devices and methods which effectively remove embolic material generated during endovascular procedures, and that can be used in vessels having various diameters.
The present invention provides an endoluminal catheter system adapted for insertion into arteries of various sizes, including the femoral artery, the iliac artery, the popliteal artery, the renal artery, the inferior mesenteric artery, the superior mesenteric artery, the celiac artery, the coronary artery, the common carotid artery, the internal carotid artery, the external carotid artery, the subclavian artery, the axillary artery, and the brachial artery. The catheter system is also adapted for insertion into a patient's venous vasculature, including the femoral vein, the iliac vein, the superficial femoral vein, the deep femoral vein, the renal vein, the coronary artery, the internal jugular vein, the external jugular vein, the subclavian vein, the saphenous vein, the azygous vein, the superior vena cava, and the inferior vena cava. The catheter system can accommodate a variety of endovascular instruments, including a blood filter, an angioplasty catheter, a valveoplasty catheter, an electrode catheter, internal vessel segregating or isolating dams, an endoscopic camera, a pressure monitor, a stent, a graft, a shunt, a perfusion catheter, and endoscopic devices.
In a first embodiment, the catheter system includes a guidewire, an endovascular catheter, e.g., angioplasty catheter, and an aspiration catheter. The guidewire has a proximal end, and an expandable occluder mounted on a distal end. The aspiration catheter has first and second lumens. The first lumen communicates between a proximal end and a distal end, and is adapted to receive the guidewire and the endovascular catheter. The second lumen communicates with at least one distal fluid infusion port. In certain embodiments, the catheter includes an aspiration lumen communicating with one or a plurality of distal aspiration ports.
In another embodiment, 2, 3, 4, 5, 6, or any other number of infusion ports are disposed radially about the distal end of the aspiration catheter. The infusion ports are shaped to direct fluid in a circular path radially and distally beyond the distal end of the aspiration catheter. In certain embodiments, the infusion ports are directed radially outward and angled relative to the radius of the catheter.
In another embodiment, the expandable occluder is mounted on a distal end of a support wire, which includes an infusion lumen and port(s). The support wire is insertable through the lumen of the endovascular catheter which includes distal aspiration port(s) and lumen.
In a first method of treating an endovascular lesion using the catheter system described above, the guidewire, which has the expandable occluder placed in a collapsed state, is inserted in the lumen of the aspiration catheter. The aspiration catheter carrying the guidewire is then inserted into a vessel, and the guidewire is advanced to position the occluder distal to a region of interest. An endovascular device, e.g., an angioplasty catheter, is inserted over the proximal end of the guidewire, and advanced to position a dilatation member within the region of interest. The aspiration catheter is advanced over the guidewire and positioned proximal the dilatation member. The occluder on the guidewire is expanded to occlude the vascular lumen distal to the lesion. The dilatation member is expanded to treat the vascular lesion and collapsed after luminal patency is achieved. Fluid, such as saline or Ringer's lactate solution, is infused through the infusion lumen and ports to irrigate the treated lumen. Fluid, blood, and embolic debris are removed through the aspiration lumen under suction. The occluder on the guidewire remains expanded during irrigation and aspiration. In certain embodiments, infusion and aspiration of fluid can create a venturi effect in the vascular lumen between the expanded occluder and the aspiration catheter to facilitate removal of loose emboli and embolic material partially attached to the vascular wall. The surgeon can tell that removal of embolic material is complete after the aspirated fluid turns from red to clear and is free of any debris. In this way, the catheter system is capable of complete removal of emboli.
In another method, fluid is infused through the lumen of a support wire to irrigate the region of interest. Embolic debris, blood, and fluid are removed through the distal aspiration ports and lumen of the endovascular catheter. Radiopaque contrast agent is infused through the infusion lumen to assess luminal patency under fluoroscopy. After treatment of the vascular lesion, the occluder is collapsed, and the catheter system is removed from the vessel.
It will be understood that there are several advantages in using the catheter systems and methods disclosed herein for treating a vascular lesion. For example, the devices (1) can be inserted in arteries or veins of various diameter, (2) provide near-total capture of embolic material, thereby dramatically reducing the risk of distal embolization, (3) accommodate a variety of endovascular instruments, and (4) provide treatment of vascular lesions and emboli protection utilizing one catheter system, thereby obviating the need for device exchange.
Referring now to the drawings, an embodiment of the catheter system for treating a vascular lesion is depicted in
In use, guidewire 10 with balloon occluder 15 in a collapsed state is inserted through an incision on a peripheral artery and advanced to vascular lesion 101 as depicted in
Angioplasty catheter 20 is inserted into lumen 33 of aspiration catheter 30 and advanced to position dilatation balloon 25 over lesion 101 as depicted in
During angioplasty, inflation of the dilatation balloon often causes fissure of an atheromatous lesion, which commonly includes calcium, cholesterol plaque, and thrombi, thereby liberating embolic debris. After the dilatation balloon is expanded against the atheromatous lesion to re-establish lumenal patency, the dilatation balloon is deflated. Radiopaque contrast agent can be infused through infusion ports 35 to assess the diameter of the vascular lumen under fluoroscopy. Fluid, such as saline or Ringer's lactate solution, is infused through infusion lumens 36 and ports 35 to irrigate the vascular region including the distal end of the angioplasty catheter as shown in
Alternatively, the distal end of angioplasty catheter 20 is withdrawn proximal, into lumen 33 of aspiration catheter 30, in certain cases, prior to irrigation and aspiration as shown in
In use, aspiration catheter 30 and guidewire 10 with balloon occluder 15 in a collapsed state are inserted into a vessel. The guidewire is advanced distal to vascular lesion 101 as depicted in
Alternatively, the distal end of catheter 50 is withdrawn into lumen 33 of aspiration catheter 30 prior to irrigation and aspiration as shown in
In use, prior to inserting support wire 70 into a vessel, balloon occluder 15 is placed in a collapsed state by closing inflation valve 19 as depicted in
The length of the aspiration catheter will generally be between approximately 40 and 120 centimeters, preferably between approximately 60 and 80 centimeters. The length of the guidewire will generally be between approximately 50 and 130 centimeters, preferably between approximately 70 to 100 centimeters. The inner diameter of the aspiration catheter will generally be between approximately 0.5 and 2.0 centimeters, preferably approximately 0.8 and 1.5 centimeters for use in the aorta. The inner diameter of the guidewire will generally be between approximately 0.005 and 0.02 inches, preferably approximately 0.008 and 0.014 inches. The diameter of the expanded occluder on the guidewire will generally be between 2 and 6 centimeters, preferably approximately 3 and 5 centimeters for use in the aorta. For use in the carotid arteries, the inner diameter of the aspiration catheter will generally be between approximately 0.2 and 1.5 centimeters, preferably approximately 0.5 and 1.0 centimeters, and the diameter of the expanded occluder on the guidewire will generally be between 1 and 3 centimeters, preferably approximately 1.5 and 2.5 centimeters. The foregoing ranges are set forth solely for the purpose of illustrating typical device dimensions. The actual dimensions of a device constructed according to the principles of the present invention may obviously vary outside of the listed ranges without departing from those basic principles.
Although the foregoing invention has, for purposes of clarity of understanding, been described in some detail by way of illustration and example, it will be obvious that certain changes and modifications may be practiced which will still fall within the scope of the appended claim. It will also be understood that each feature of each embodiment discussed herein, and of each reference cited herein, can be used in combination with the features of any other embodiment.
This is a continuation application of U.S. application Ser. No. 09/470,026 filed Dec. 22, 1999, now abandoned.
Number | Name | Date | Kind |
---|---|---|---|
3472230 | Fogarty | Oct 1969 | A |
3952747 | Kimmell, Jr. | Apr 1976 | A |
3996938 | Clark, III | Dec 1976 | A |
4425908 | Simon | Jan 1984 | A |
4643184 | Mobin-Uddin | Feb 1987 | A |
4662885 | DiPisa, Jr. | May 1987 | A |
4706671 | Weinrib | Nov 1987 | A |
4723549 | Wholey et al. | Feb 1988 | A |
4790812 | Hawkins, Jr. et al. | Dec 1988 | A |
4790813 | Kensey | Dec 1988 | A |
4794928 | Kletschka | Jan 1989 | A |
4857045 | Rydell | Aug 1989 | A |
4873978 | Ginsburg | Oct 1989 | A |
4886061 | Fischell et al. | Dec 1989 | A |
4950238 | Sullivan | Aug 1990 | A |
4969891 | Gewertz | Nov 1990 | A |
RE33569 | Gifford, III et al. | Apr 1991 | E |
5011488 | Ginsburg | Apr 1991 | A |
5071407 | Termin et al. | Dec 1991 | A |
5116317 | Carson et al. | May 1992 | A |
5133733 | Rasmussen et al. | Jul 1992 | A |
5160342 | Reger et al. | Nov 1992 | A |
5192286 | Phan et al. | Mar 1993 | A |
5324304 | Rasmussen | Jun 1994 | A |
5329942 | Gunther et al. | Jul 1994 | A |
5370657 | Irie | Dec 1994 | A |
5415630 | Gory et al. | May 1995 | A |
5419774 | Willard et al. | May 1995 | A |
5462529 | Simpson et al. | Oct 1995 | A |
5536242 | Willard et al. | Jul 1996 | A |
5549626 | Miller et al. | Aug 1996 | A |
5662671 | Barbut et al. | Sep 1997 | A |
5669933 | Simon et al. | Sep 1997 | A |
5769816 | Barbut et al. | Jun 1998 | A |
5779716 | Cano et al. | Jul 1998 | A |
5800457 | Gelbfish | Sep 1998 | A |
5800525 | Bachinski et al. | Sep 1998 | A |
5807398 | Shaknovich | Sep 1998 | A |
5814064 | Daniel et al. | Sep 1998 | A |
5833650 | Imran | Nov 1998 | A |
5843022 | Willard et al. | Dec 1998 | A |
5848964 | Samuels | Dec 1998 | A |
5873889 | Chin | Feb 1999 | A |
5911734 | Tsugita et al. | Jun 1999 | A |
5928181 | Coleman et al. | Jul 1999 | A |
5938645 | Gordon | Aug 1999 | A |
6013085 | Howard | Jan 2000 | A |
6022336 | Zadno-Azizi et al. | Feb 2000 | A |
6066149 | Samson et al. | May 2000 | A |
6066158 | Engelson et al. | May 2000 | A |
6080170 | Nash et al. | Jun 2000 | A |
6126635 | Simpson et al. | Oct 2000 | A |
6142987 | Tsugita | Nov 2000 | A |
6146370 | Barbut | Nov 2000 | A |
6152946 | Broome et al. | Nov 2000 | A |
6156048 | Wulfman et al. | Dec 2000 | A |
6165196 | Stack et al. | Dec 2000 | A |
6168579 | Tsugita | Jan 2001 | B1 |
6171327 | Daniel et al. | Jan 2001 | B1 |
6179861 | Khosravi et al. | Jan 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6190355 | Hastings | Feb 2001 | B1 |
6190357 | Ferrari et al. | Feb 2001 | B1 |
6193685 | Goodin | Feb 2001 | B1 |
6203561 | Ramee et al. | Mar 2001 | B1 |
6206868 | Parodi | Mar 2001 | B1 |
6221006 | Dubrul et al. | Apr 2001 | B1 |
6254571 | Hart | Jul 2001 | B1 |
6277139 | Levinson et al. | Aug 2001 | B1 |
6398773 | Bagaoisan et al. | Jun 2002 | B1 |
6423032 | Parodi | Jul 2002 | B2 |
6443922 | Roberts et al. | Sep 2002 | B1 |
6443924 | Rowland et al. | Sep 2002 | B1 |
6451043 | McInnes et al. | Sep 2002 | B1 |
6454741 | Muni et al. | Sep 2002 | B1 |
6485500 | Kokish et al. | Nov 2002 | B1 |
6503224 | Forman et al. | Jan 2003 | B1 |
6544276 | Azizi | Apr 2003 | B1 |
6558401 | Zadno-Azizi | May 2003 | B1 |
6589214 | McGuckin, Jr. et al. | Jul 2003 | B2 |
6595953 | Coppi et al. | Jul 2003 | B1 |
6605102 | Mazzocchi et al. | Aug 2003 | B1 |
6652546 | Nash et al. | Nov 2003 | B1 |
6669662 | Webler | Dec 2003 | B1 |
6682505 | Bates et al. | Jan 2004 | B2 |
6682543 | Barbut et al. | Jan 2004 | B2 |
6749619 | Ouriel et al. | Jun 2004 | B2 |
6755813 | Ouriel et al. | Jun 2004 | B2 |
6805692 | Muni et al. | Oct 2004 | B2 |
6849068 | Bagaoisan et al. | Feb 2005 | B1 |
20010039411 | Johansson et al. | Nov 2001 | A1 |
20010044598 | Parodi | Nov 2001 | A1 |
20010047147 | Slepian et al. | Nov 2001 | A1 |
20010047184 | Connors | Nov 2001 | A1 |
20010049517 | Zadno-Azizi et al. | Dec 2001 | A1 |
20010056274 | Perkins et al. | Dec 2001 | A1 |
20020016564 | Courtney et al. | Feb 2002 | A1 |
20020016565 | Zadno-Azizi et al. | Feb 2002 | A1 |
20020065507 | Zadno-Azizi | May 2002 | A1 |
20020091362 | Maginot et al. | Jul 2002 | A1 |
20020091407 | Zadno-Azizi et al. | Jul 2002 | A1 |
20020165574 | Ressemann et al. | Nov 2002 | A1 |
20020169436 | Gurm et al. | Nov 2002 | A1 |
20020183826 | Dorn et al. | Dec 2002 | A1 |
20020188276 | Evans et al. | Dec 2002 | A1 |
20030009146 | Muni et al. | Jan 2003 | A1 |
20030050600 | Ressemann et al. | Mar 2003 | A1 |
20030130673 | Trerotola | Jul 2003 | A1 |
20030163081 | Constantz et al. | Aug 2003 | A1 |
20040006306 | Evans et al. | Jan 2004 | A1 |
20040054347 | Zadno-Azizi et al. | Mar 2004 | A1 |
20040059372 | Tsugita | Mar 2004 | A1 |
20040064179 | Linder et al. | Apr 2004 | A1 |
20040098022 | Barone | May 2004 | A1 |
20040122362 | Houser et al. | Jun 2004 | A1 |
20040153094 | Dunfee et al. | Aug 2004 | A1 |
20040220521 | Barbut | Nov 2004 | A1 |
20050065460 | Laird | Mar 2005 | A1 |
20050065469 | Tai | Mar 2005 | A1 |
20050085769 | MacMahon et al. | Apr 2005 | A1 |
20050124849 | Barbut et al. | Jun 2005 | A1 |
20050131446 | Coughlin et al. | Jun 2005 | A1 |
20050131453 | Parodi | Jun 2005 | A1 |
20050148997 | Valley et al. | Jul 2005 | A1 |
20050149103 | Connors, III | Jul 2005 | A1 |
20050154344 | Chang et al. | Jul 2005 | A1 |
20050159640 | Barbut et al. | Jul 2005 | A1 |
20050228432 | Hogendijk et al. | Oct 2005 | A1 |
20050245866 | Zadno-Azizi | Nov 2005 | A1 |
20050245894 | Zadno-Azizi | Nov 2005 | A1 |
Number | Date | Country |
---|---|---|
9601591 | Jan 1996 | WO |
Number | Date | Country | |
---|---|---|---|
20060041304 A1 | Feb 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09470026 | Dec 1999 | US |
Child | 11220227 | US |